Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions: a Double-blind Randomized Clinical Trial

NCT04187417 is registered in ClinicalTrials.gov with INTEGRIS Southwest Medical Center as lead sponsor.

NCT NCT04187417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04187417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions: a Double-blind Randomized Clinical Trial
Lead sponsor
INTEGRIS Southwest Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2015
Completion date
September 30, 2018
Enrollment
118 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

corneal abrasion